Topaz Pharmaceuticals Inc Report issue

For profit Phase 3
Founded: Horsham PA United States (2005)
Status: Acquired by Sanofi-Aventis (2011)

Organization Overview

First Clinical Trial
2009
NCT00857948
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

ivermectin (stromectol) (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 3)

Parasitic Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 1